 |
|
Ask the BIZS (Bureau of Immunization Services) Experts
Clinical answers to vaccine questions
|
The 2025 Immunization Schedules approved by ACIP and adopted by the CDC Director on October 24, 2024 are now available.
Child and Adolescent Immunization Schedule by Age
Guide health care providers in determining recommended vaccines for each age group.
Adult Immunization Schedule by Age
Stay up-to-date on getting recommended vaccines. View and print CDC immunization schedules for adults.
|
|
 |
There are several notable 2025 CDC schedule changes from 2024.
-
COVID-19 note was revised to provide guidance for use of 2024-2025 COVID-19 vaccines.
-
Diphtheria, tetanus and acellular pertussis (DTaP) note addresses the use of Td vaccine in children under 7 years with a contraindication to the pertussis component of DTaP.
-
Haemophilus influenzae type b (Hib) note was revised to include preferential use of Vaxelis or PedvaxHIB for primary doses in American Indian and Alaska Native infants.
-
Hepatitis B was revised to include Heplisav-B to the list of vaccine products that can be administered during pregnancy.
-
Influenza vaccines were changed from the quadrivalent to trivalent formulation to be consistent with the vaccine products approved by the Food and Drug Administration for the 2024-2025 influenza season.
-
Meningococcal B: Bexsero dosing has been changed to a two-dose series for healthy adolescents and a three-dose series for those at increased risk of disease. Patients who need rapid protection (such as during an outbreak) can choose a three-dose series.
-
Measles, mumps, rubella note indicates children 12 months and older vaccinated with one dose should get a second dose at least four weeks after the first if they are going to travel internationally.
-
Inactivated poliovirus catch-up vaccination is recommended for 18-year-olds who are known or suspected to be unvaccinated or incompletely unvaccinated.
-
Respiratory syncytial virus (RSV) immunization note clarifies that for infants born in October through March, the ideal timing of nirsevimab administration is during the birth hospitalization. In addition, infants born to people who received an RSV vaccine during a previous pregnancy should receive nirsevimab.
-
Respiratory syncytial virus (RSV) vaccination note clarifies that additional doses are not recommended in subsequent pregnancies.
As the CDC updates policies throughout the year, addenda will be added to the online schedules.
Check immunize.org for updates on when laminated versions of the updated 2025 Schedules will be available for purchase.
References:
Immunization Schedules | Vaccines & Immunizations | CDC
Vaccine Schedules For You and Your Family | Vaccines & Immunizations | CDC
Schedule Changes & Guidance | Vaccines & Immunizations | CDC
CDC releases 2025 immunization schedules | AAP News | American Academy of Pediatrics
The Bureau of Immunization Services (BIZS) has clinical staff available to assist with your immunization questions. Contact the following individuals (or your county health department) for assistance:
Kate Whitman, MSE, BSN, Kathleen.Whitman@azdhs.gov, 480-259-5342
Sharon Sweeney, MPH, BSN, Sharon.Sweeney@azdhs.gov, 480-261-5557
|
